Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 166, Issue 5, pp 631–636 | Cite as

Amino Acid Substitutions N123D and N149D in Hemagglutinin Molecule Enhance Immunigenicity of Live Attenuated Influenza H7N9 Vaccine Strain in Experiment

  • E. A. StepanovaEmail author
  • T. S. Kotomina
  • V. A. Matyushenko
  • T. A. Smolonogina
  • V. S. Shapovalova
  • L. G. Rudenko
  • I. N. Isakova-Sivak
VIROLOGY

We compared three cold-adapted live attenuated influenza vaccine strains prepared by reverse genetics methods on the basis of master donor virus A/Leningrad/134/17/57 and influenza H7N9 strains A/Anhui/1/2013 and A/Shanghai/1/2013. Two strains based on A/Anhui/1/2013 differed by amino acid positions 123 and 149 in HA1 (123N/149N; 123D/149D). All strains efficiently replicated in developing chicken embryos; A/Shanghai/1/2013-based strain and A/Anhui/1/2013-123N/149N variant were characterized by reduced replication in MDCK cells. Strains based on A/Anhui/1/2013 virus agglutinated erythrocytes with α2,3- and α2,6-linked sialic acid residues, whereas strain A/Shanghai/1/2013 only α2,3. In experiments with BALB/c mice, Anhui-123D/149D strain was most immunogenic and induced high crossreactive humoral immune response, therefore it can be recommended as the model virus for the construction of recombinant vector vaccines based on live attenuated influenza vaccine.

Key Words

influenza live attenuated influenza vaccine immunogenicity hemagglutinin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Air GM. Influenza neuraminidase. Influenza Other Respir. Viruses. 2012;6(4):245-256.CrossRefGoogle Scholar
  2. 2.
    Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets. J. Virol. 2014;88(12):7016-7023.CrossRefGoogle Scholar
  3. 3.
    Goff PH, Krammer F, Hai R, Seibert CW, Margine I, García-Sastre A, Palese P. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J. Virol. 2013;87(14):8235-8240.CrossRefGoogle Scholar
  4. 4.
    Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch Hv, Klimov A, Rudenko L, Cox NJ, Donis RO. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology. 2011;412(2):297-305.CrossRefGoogle Scholar
  5. 5.
    Isakova-Sivak I, Tretiak T, Rudenko L. Cold-adapted influenza viruses as a promising platform for viral-vector vaccines. Expert Rev. Vaccines. 2016;15(10):1241-1243.CrossRefGoogle Scholar
  6. 6.
    de Jonge J, Isakova-Sivak I, van Dijken H, Spijkers S, Mouthaan J, de Jong R, Smolonogina T, Roholl P, Rudenko L. H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. Mol. Ther. 2016;24(5):991-1002.CrossRefGoogle Scholar
  7. 7.
    Kile JC, Ren R, Liu L, Greene CM, Roguski K, Iuliano AD, Jang Y, Jones J, Thor S, Song Y, Zhou S, Trock SC, Dugan V, Wentworth DE, Levine MZ, Uyeki TM, Katz JM, Jernigan DB, Olsen SJ, Fry AM, Azziz-Baumgartner E, Davis CT. Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic — China, October 1, 2016—August 7, 2017. Morb. Mortal Wkly Rep. 2017;66(35):928-932.CrossRefGoogle Scholar
  8. 8.
    Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology. 1997;233(1):224-234.CrossRefGoogle Scholar
  9. 9.
    Pantin-Jackwood MJ, Miller PJ, Spackman E, Swayne DE, Susta L, Costa-Hurtado M, Suarez DL. Role of poultry in the spread of novel H7N9 influenza virus in China. J. Virol. 2014;88(10):5381-5390.CrossRefGoogle Scholar
  10. 10.
    Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, van Boheemen S, de Meulder D, Lexmond P, Linster M, Herfst S, Smith DJ, van den Brand JM, Burke DF, Kuiken T, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature. 2013;501:560-563.CrossRefGoogle Scholar
  11. 11.
    Rudenko L, Isakova-Sivak I, Naykhin A, Kiseleva I, Stukova M, Erofeeva M, Korenkov D, Matyushenko V, Sparrow E, Kieny MP. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2016;16(3):303-310.CrossRefGoogle Scholar
  12. 12.
    Shcherbik S, Pearce N, Balish A, Jones J, Thor S, Davis CT, Pearce M, Tumpey T, Cureton D, Chen LM, Villanueva J, Bousse TL. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation. PLoS One. 2015;10(9):e0138951. doi:  https://doi.org/10.1371/journal.pone.0138951.CrossRefGoogle Scholar
  13. 13.
    Shi Y, Zhang W, Wang F, Qi J, Wu Y, Song H, Gao F, Bi Y, Zhang Y, Fan Z, Qin C, Sun H, Liu J, Haywood J, Liu W, Gong W, Wang D, Shu Y, Wang Y, Yan J, Gao GF. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science. 2013;342:243-247.CrossRefGoogle Scholar
  14. 14.
    Suptawiwat O, Kongchanagul A, Chan-It W, Thitithanyanont A, Wiriyarat W, Chaichuen K, Songserm T, Suzuki Y, Puthavathana P, Auewarakul P. A simple screening assay for receptor switching of avian influenza viruses. J. Clin. Virol. 2008;42(2):186-189.CrossRefGoogle Scholar
  15. 15.
    Yang H, Carney PJ, Chang JC, Villanueva JM, Stevens J. Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus. J. Virol. 2013;87(22):12,433-12,446.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • E. A. Stepanova
    • 1
    Email author
  • T. S. Kotomina
    • 1
  • V. A. Matyushenko
    • 1
  • T. A. Smolonogina
    • 1
  • V. S. Shapovalova
    • 1
  • L. G. Rudenko
    • 1
  • I. N. Isakova-Sivak
    • 1
  1. 1.A. A. Smorodintsev Department of Virology, Institute of Experimental MedicineSt. PetersburgRussia

Personalised recommendations